Ravi Shastri said India now had its most potent pace attack of all time following a crushing 203-run victory over England in the third Test at Trent Bridge.
India's pacemen took 19 out of 20 England wickets in Nottingham before Ravichandran Ashwin, an off-spinner, ended the match just 10 minutes into Wednesday's fifth and final day by dismissing No 11 James Anderson.
Because the dry and dusty pitches often found in India traditionally favour spinners, their Test attacks were once dominated by slow bowlers.
But it was a very different story as the pacemen held sway at Trent Bridge, with all-rounder Hardik Pandya taking five for 28 in England's first innings 161 and fast bowler Jasprit Bumrah five for 85 in the hosts' second innings 317.
Moreover, India also have the likes of Bhuvneshwar Kumar and Umesh Yadav waiting in the wings.
Team coach Shastri, asked if India now had their best pace attack of all time, told reporters: "By a mile, by a mile. No (other India) team comes even close."
- Bumrah surprise -
Bumrah bowled a marathon 26 overs during Tuesday's play, a feat made all the more remarkable by the fact this was his first competitive match since suffering a thumb injury in a Twenty20 international against Ireland in Dublin on June 27.
"He is different, he is like when (Lasith) Malinga came on the scene or a Mitchell Johnson," said Shastri of the 24-year-old Bumrah, who only played the first of his four career Test against South Africa in Cape Town in January.
"He has that element of surprise... With that long spell he surprised us as well -- almost 30 overs in that one innings, for someone who has not played for a month and a half is commendable."
India may be the world's top-ranked Test side but in the past five years they have won just one of their six previous series outside of Asia, against a struggling West Indies.
But Shastri who has been involved in India's backroom set-up since 2014, initially as team director, was adamant they could be a force abroad.
"In the four years I've been doing this job, I think if you look at a clinical performance overseas, I think this has to be the best.
"When you look at all three departments, they stood up. As a batting unit, as a catching unit and as a bowling unit, so you can't ask for more.
"The endeavour of this team is to be the best travelling team in the world," former spin-bowling all-rounder Shastri, a member of the India side that won 2-1 in England in 1986, added.
"And I believe they're almost there. In India, we know what we can do. Especially if we play in conditions that suit us, very few teams will have a sniff.
"But to go to South Africa, England, Australia and try and win there, that's the endeavour of this team and they have it in them," the 56-year-old insisted.
- 'Champion Kohli' -
India's comprehensive win in Nottingham -- just their seventh Test-match victory in England -- followed a huge innings and 159-run defeat by England at Lord's after a narrow loss in the series opener at Edgbaston.
"All I asked the boys was to give me some accountability and they were simply magnificent," said Shastri, who attributed the vastly improved performance to "mental rest".
Trent Bridge also proved a triumph for Virat Kohli, the India captain's innings of 97 and 103 seeing the star batsman named man-of-the-match.
"What can you say about him?," said Shastri. "All you can say is 'well played', there is nothing else to say.
"He is a champion player."
India are bidding to become just the second team in Test history to win a five-match series from 2-0, with a Don Bradman-inspired Australia the only side to have achieved that feat when they defeated England back in 1936/37.
But Shastri brushed aside the comparison ahead of the fourth Test in Southampton, which starts on August 30.
"One match at a time, we live in the present," he said. "We move to Southampton and start afresh, take a fresh guard."
Universal Pictures releases poster for Nolan’s upcoming epic The Odyssey.
Teaser trailer only available in cinemas before Jurassic World Rebirth.
Matt Damon stars as Odysseus in the film set for release on 17 July 2026.
Ensemble cast includes Tom Holland, Zendaya, Anne Hathaway, and more.
Oscar-winning director Christopher Nolan is officially delving into mythology. His upcoming film The Odyssey, a retelling of Homer’s epic tale, has just dropped its first poster, and a short teaser trailer is now being shown exclusively in cinemas alongside Jurassic World Rebirth.
The poster leans into the film’s mythological roots, featuring the image of a fractured Greek sculpture engulfed in embers, with the words “Defy the Gods” stamped across the middle. It also confirms the theatrical release date: 17 July 2026.
Matt Damon plays Odysseus in Nolan’s mythological epic
At the heart of this ambitious project is Matt Damon, returning to work with Nolan to play the Greek hero Odysseus. The teaser trailer, currently unavailable online, reportedly shows Damon adrift at sea and includes brief appearances by Tom Holland as his son Telemachus and Jon Bernthal in an unspecified role. This marks the first time Nolan has adapted a classical myth, a shift from his previous grounded, cerebral storytelling in films like Oppenheimer, Inception, and Dunkirk.
Teaser trailer only in theatres—no online release yet
In typical Nolan fashion, the teaser for The Odyssey has not been released online and is only viewable in select cinemas. The 70-second clip features dramatic glimpses of the lead characters and a haunting tone, reaffirming Nolan’s love for the theatrical experience. Leaks of the trailer have surfaced on social media, but Universal is yet to respond or confirm an official online release date.
Christopher Nolan’s The Odyssey poster debuts in cinemas with exclusive teaser trailerGetty Images
Nolan reteams with Universal after Oppenheimer success
Nolan’s The Odyssey follows his Oscar-winning Oppenheimer, which earned seven Academy Awards, including Best Picture and Best Director. With a reported budget of £197 million (₹2,080 crore), The Odyssey is Nolan’s most expensive film to date. The film is produced by Nolan’s long-time collaborator and wife, Emma Thomas, and shot using advanced IMAX technology. It continues Nolan’s new partnership with Universal after parting ways with Warner Bros.
Alongside Damon and Holland, the film features an ensemble cast including Anne Hathaway, Zendaya, Lupita Nyong’o, Robert Pattinson, Charlize Theron, Elliot Page, Himesh Patel, and John Leguizamo.
With such a high-profile line-up and one of cinema’s most respected directors at the helm, The Odyssey is expected to be one of the biggest releases of 2026.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Serious public health challenges in the decades ahead
Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
Black women are expected to experience the highest increase in incidence-based mortality.
A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
Researchers stress the urgent need for improved prevention and early detection strategies.
Sharp increase in uterine cancer predicted over next three decades
Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.
This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.
Black women to face disproportionate increase in mortality
The study found that Black women already experience double the mortality rate from uterine cancer compared to women from other racial and ethnic backgrounds. Using a predictive model, researchers estimated that this gap will widen dramatically by 2050.
The incidence-based mortality rate among Black women is expected to rise from 14.1 per 100,000 in 2018 to 27.9 per 100,000 by 2050. In contrast, for White women, the rate will increase from 6.1 per 100,000 to 11.2 per 100,000 in the same period.
The incidence rate is also projected to rise to 86.9 cases per 100,000 in Black women and 74.2 cases per 100,000 in White women by 2050, compared to 56.8 and 57.7, respectively, in 2018.
About the study model
The projections were developed using the Columbia University Uterine Cancer Model (CU-UTMO), a state-transition microsimulation tool designed as part of the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET).
The model simulates the disease trajectory based on age (18–84), race (Black and White), tumour type (endometrioid or nonendometrioid), stage at diagnosis, and birth cohort from 1910 onwards. It was validated using 2018 data and showed a strong fit to actual incidence and mortality statistics.
Lead author Dr Jason D. Wright, the Sol Goldman Professor of Gynaecologic Oncology at Columbia University, explained:
“There are likely a number of factors that are associated with the increased burden of uterine cancer in Black women. They more commonly have aggressive types of uterine cancer, face delayed diagnosis resulting in later-stage disease at diagnosis, and there are often delays in their treatment.”
More aggressive tumour types in Black women
The model also highlighted that while endometrioid tumours, a less aggressive form, are projected to increase in both Black and White women, the rate of nonendometrioid tumours, which have a poorer prognosis, will rise considerably in Black women alone.
These trends point to an urgent need for improved public health interventions aimed at early diagnosis and treatment, as well as research into tailored approaches for high-risk groups.
Potential for prevention and screening
In a stress test of the model, researchers incorporated hypothetical screening methods capable of detecting uterine cancer and precancerous changes before clinical diagnosis. The analysis found that such interventions could lead to significant reductions in cancer incidence, lasting up to 15 years in White women and 16 years in Black women, if introduced at the age of 55.
Dr Wright commented on the implications of the test:
“The stress testing suggests that if there was an effective screening test, we may be able to substantially reduce the burden of disease. While there is presently no screening or prevention that is routinely used for uterine cancer, we are currently examining the potential impact of integrating screening into practice.”
Call for action
With cases and deaths from uterine cancer projected to climb, the researchers conclude that immediate steps must be taken to develop and implement primary and secondary prevention strategies. Without intervention, the burden of uterine cancer, particularly among Black women, is expected to grow significantly, posing serious public health challenges in the decades ahead.
Deepika Padukone to be honoured with a Hollywood Walk of Fame star in 2026 under the Motion Pictures category.
She is the first Indian actress to receive the recognition, announced by the Hollywood Chamber of Commerce.
The Class of 2026 also includes Emily Blunt, Rami Malek, Timothée Chalamet and Miley Cyrus.
Deepika expressed her gratitude on Instagram, calling the moment “Gratitude…”.
Deepika Padukone has been named among the 2026 honourees for the Hollywood Walk of Fame, becoming the first Indian actress to receive the distinction. The announcement, made during a live event hosted by the Hollywood Chamber of Commerce, places her alongside a global line-up of actors, musicians, and broadcasters to be celebrated with their own stars on Hollywood Boulevard next year.
Deepika Padukone to get Hollywood Walk of Fame star Getty Images
Hollywood Walk of Fame committee selects Deepika for Motion Pictures category
Deepika’s name was included in the Motion Pictures category, joining a list of 35 individuals from across entertainment. This year’s selection includes actors Emily Blunt, Rachel McAdams, Rami Malek, and Timothée Chalamet, among others. Past inductee Eugenio Derbez and radio host Richard Blade revealed the names via livestream. The committee evaluated hundreds of entries before selecting honourees based on their artistic contributions, public appeal, and philanthropic work.
Jury Member Deepika Padukone attend the Palme D'or winner press conference Getty Images
Deepika Padukone’s international journey and Hollywood debut
Padukone’s inclusion, in fact, reflects her global appeal. After rising to fame in Bollywood, she entered Hollywood with the 2017 action film xXx: Return of Xander Cage, co-starring Vin Diesel. Since then, she has represented Indian cinema on international platforms such as Cannes and the Met Gala. Earlier this year, she featured in Kalki 2898 AD, one of India’s highest-grossing films, and is currently attached to Atlee’s next project alongside Allu Arjun.
Deepika Padukone honoured with Hollywood star in 2026 Getty Images
No, celebrities can’t buy their way into the Walk of Fame
With each announcement, speculation swirls online about whether stars purchase this honour. However, Walk of Fame officials clarified that selections are made through a transparent process. Anyone can submit a nomination, but it must be supported by the artist and meet strict criteria, including a minimum of five years in the industry and verifiable public impact. A sponsor later pays a fee, currently between £59,000 (₹6.2 crore) and £66,000 (₹7 crore), used for maintenance, not for purchase of the star itself.
Deepika Padukone becomes Walk of Fame honouree in 2026Getty Images
Not the first Indian name, but a major milestone for Indian cinema
While Deepika’s recognition marks a landmark for Indian women in cinema, she is not the first Indian to appear on the Walk. That honour goes to Sabu Dastagir, a Mysore-born actor who became a Hollywood sensation in the 1930s and received his star in 1960. Nevertheless, Padukone’s inclusion underscores a new era of global visibility for Indian actors.
Last week, I had the privilege of speaking at the Circles of Connections event hosted by the Society of Jainism and Entrepreneurship at Imperial College London. The event was organised by Yash Shah and Hrutika S., and generously sponsored by Koolesh Shah and the London Town Group, with support from Nikhil Shah, Priyanka Mehta, and Ambika Mehta.
The experience reminded me that leadership isn’t just about vision or results — it’s about how you show up, and why you do what you do.
Hatul Shah
During my talk, I shared stories from my journey in business and reflected on how the principles of Jainism have quietly shaped the way I lead. I’m not a strict Jain, but I deeply respect the values passed down to me by my grandfather and father. Three in particular — Ahimsa (non-violence), Satya (truth and transparency), and Dana (charity through entrepreneurial spirit) — have become anchors in how I make decisions, lead teams, build culture, and, most importantly, how I treat people.
These values don’t just influence your actions. They define your identity — and over time, they shape how others experience your leadership.
It was energising to connect with students, emerging entrepreneurs, and peers — each on their own journey, yet all driven by purpose and values.
Leadership and legacy are not separate tracks. The strongest leaders carry both — and pass them forward.
(This reflection was originally shared on LinkedIn by Hatul Shah, CEO of Sigma Pharmaceuticals.)
Do you have a knack for making money or an eye for emerging trends? Are you looking for a unique challenge? We are searching nationwide for teams of two to compete in a new series set in the high-stakes art world. If you’re enthusiastic or simply curious about art, we’re offering an opportunity to take part in a one-of-a-kind experience and the chance to win £50k worth of art!